69 related articles for article (PubMed ID: 38514186)
1. Prevention and treatment of HPV-related cancer through a mRNA vaccine expressing APC-targeting antigen.
Li X; Wang H; Lai W; Liao J; Mo W; Huang K; He L; Liang X; Yu Z; Xu J; Hua X; Hou F; Ding J; Jia WW; Zhang K; Wang Y
Immunology; 2024 Jul; 172(3):375-391. PubMed ID: 38471664
[TBL] [Abstract][Full Text] [Related]
2. TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers.
Barrios K; Celis E
Cancer Immunol Immunother; 2012 Aug; 61(8):1307-17. PubMed ID: 22527249
[TBL] [Abstract][Full Text] [Related]
3. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P
Front Immunol; 2020; 11():188. PubMed ID: 32133000
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies.
Wang J; Ma L; Chen Y; Zhou R; Wang Q; Zhang T; Yi D; Liu Q; Zhang Y; Zhang W; Dong Y; Cen S
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38514186
[TBL] [Abstract][Full Text] [Related]
5. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
6. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
Esquerré M; Momot M; Goubier A; Gonindard C; Leung-Theung-Long S; Misseri Y; Bissery MC
Vaccine; 2017 Mar; 35(11):1509-1516. PubMed ID: 28196735
[TBL] [Abstract][Full Text] [Related]
7. A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors.
Wick DA; Webb JR
Vaccine; 2011 Oct; 29(44):7857-66. PubMed ID: 21816200
[TBL] [Abstract][Full Text] [Related]
8. A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses.
Han X; Gao Z; Cheng Y; Wu S; Chen J; Zhang W
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895145
[TBL] [Abstract][Full Text] [Related]
9. mRNA-HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV-mediated cancers via subcutaneous immunization.
Lee S; Yoon H; Hong SH; Kwon SP; Hong JJ; Kwak HW; Park HJ; Yoo S; Bae SH; Park HJ; Lee J; Bang YJ; Lee YS; Kim JY; Yoon S; Roh G; Cho Y; Kim Y; Kim D; Park SI; Kim DH; Lee S; Oh A; Ha D; Lee SY; Park M; Hwang EH; Bae G; Jeon E; Park SH; Choi WS; Oh HR; Kim IW; Youn H; Keum G; Bang EK; Rhee JH; Lee SE; Nam JH
J Med Virol; 2023 Dec; 95(12):e29309. PubMed ID: 38100632
[TBL] [Abstract][Full Text] [Related]
10. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability.
Zhang L; More KR; Ojha A; Jackson CB; Quinlan BD; Li H; He W; Farzan M; Pardi N; Choe H
NPJ Vaccines; 2023 Oct; 8(1):156. PubMed ID: 37821446
[TBL] [Abstract][Full Text] [Related]
11. mRNA-LNP vaccination-based immunotherapy augments CD8
Qiu K; Duan X; Mao M; Song Y; Rao Y; Cheng D; Feng L; Shao X; Jiang C; Huang H; Wang Y; Li H; Chen X; Wu S; Luo D; Chen F; Peng X; Zheng Y; Wang H; Liu J; Zhao Y; Song X; Ren J
NPJ Vaccines; 2023 Sep; 8(1):144. PubMed ID: 37773254
[TBL] [Abstract][Full Text] [Related]
12. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice.
Ramos da Silva J; Bitencourt Rodrigues K; Formoso Pelegrin G; Silva Sales N; Muramatsu H; de Oliveira Silva M; Porchia BFMM; Moreno ACR; Aps LRMM; Venceslau-Carvalho AA; Tombácz I; Fotoran WL; Karikó K; Lin PJC; Tam YK; de Oliveira Diniz M; Pardi N; de Souza Ferreira LC
Sci Transl Med; 2023 Mar; 15(686):eabn3464. PubMed ID: 36867683
[TBL] [Abstract][Full Text] [Related]
13. Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy.
Wang HL; Wang ZG; Liu SL
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080373
[TBL] [Abstract][Full Text] [Related]
14. Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1.
Lee HH; Hong SH; Rhee JH; Lee SE
Transl Cancer Res; 2022 Jun; 11(6):1595-1602. PubMed ID: 35836530
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]